Company
Zealand Pharma
Zealand Pharma has 13 drugs tracked on RxWires: 3 in Phase 3, 5 in Phase 2, 4 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| glepaglutide | Phase 3 | Short Bowel Syndrome |
| Dasiglucagon | Phase 3 | Hypoglycemia |
| Enzalutamide | Phase 3 | Prostatic Neoplasms |
| ZP4207 | Phase 2 | Hypoglycemia |
| Petrelintide | Phase 2 | Overweight |
| danegaptide | Phase 2 | Focus of Study is STEMI |
| ZP1848 | Phase 2 | Short Bowel Syndrome |
| ZP4207(dasiglucagon) glucagon analogue | Phase 2 | Diabetes Mellitus Type 1 |
| ZP9830 | Phase 1 | Healthy Volunteers |
| ZP8396 | Phase 1 | Overweight |
| ZP7570 | Phase 1 | Healthy |
| ZP6590, solution for injection | Phase 1 | Healthy Participants Study |
| GIP1-42 infusion | Not Applicable | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Zealand Pharma on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.